Short Glenn Frank 4

What Happened Glenn Short, Chief Scientific Officer of AtaiBeckley Inc. (ATAI), received equity awards on January 30, 2026 consisting of a 675,000-share stock option grant and 150,000 restricted stock units (RSUs). Both awards are reported as derivative acquisitions with an acquisition price of $0. These are compensation awards (not open-market purchases or sales).

Key Details

• Transaction date: January 30, 2026; filing date: February 3, 2026.
• Grants: 675,000 stock options (derivative) and 150,000 RSUs (derivative) — 825,000 total; reported acquisition price $0.
• Shares owned after transaction: not disclosed in the Form 4 filing.
• Vesting (footnotes):
  • Options (F1): 25% vests January 1, 2027, then the remaining 75% vests in 36 substantially equal monthly installments thereafter (subject to continued service).
  • RSUs (F2): 25% vests January 1, 2027, and the remaining 75% vests in three equal amounts on each of the first three anniversaries of January 1, 2027 (subject to continued service).
• Filing includes Exhibit 24 (Power of Attorney) in remarks.

Context These are time-based compensation awards to an executive; they do not represent a market purchase or sale and do not generate immediate proceeds. The options and RSUs vest over multiple dates, meaning the executive must remain employed through those vesting milestones to realize value. Form 4 disclosures are factual records of the grants and vesting terms and do not, by themselves, indicate an insider’s view on the company’s stock.